GNGClass I
Antigens, Cf (Including Cf Control), Coxsackievirus A 1-24, B 1-6
21 CFR 866.3145 / Microbiology
GNG is the FDA product code for Antigens, Cf (Including Cf Control), Coxsackievirus A 1-24, B 1-6, a class I device type, regulated under 21 CFR 866.3145. As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- GNG
- Device name
- Antigens, Cf (Including Cf Control), Coxsackievirus A 1-24, B 1-6
- Regulation
- 21 CFR 866.3145
- Device class
- Class I
- Review panel
- Microbiology
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 2
- Ingested recalls
- 0
Clearances, product code GNG
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1985 | 1 |
| 1992 | 1 |
Applicants with the most clearances
Product code GNG| Applicant | Clearances |
|---|---|
| Hillcrest Biologicals | 1 |
| Virion (U.S.), Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeNo registered establishment in MDM’s records lists product code GNG.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
